232 related articles for article (PubMed ID: 22091305)
21. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran.
Zahiri Z; Sharami SH; Milani F; Mohammadi F; Kazemnejad E; Ebrahimi H; Dalil Heirati SF
Int J Fertil Steril; 2016; 9(4):490-6. PubMed ID: 26985336
[TBL] [Abstract][Full Text] [Related]
23. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
24. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran.
Pourteymour Fard Tabrizi F; Alipoor B; Mehrzad Sadaghiani M; Ostadrahimi A; Malek Mahdavi A
Int J Fertil Steril; 2013 Jan; 6(4):244-9. PubMed ID: 24520447
[TBL] [Abstract][Full Text] [Related]
26. Prediction of metabolic syndrome in women with polycystic ovary syndrome.
Ersan F; Arslan E; Esmer AÇ; Aydın S; Gedikbaşı A; Gedikbaşı A; Alkış I; Ark C
J Turk Ger Gynecol Assoc; 2012; 13(3):178-83. PubMed ID: 24592034
[TBL] [Abstract][Full Text] [Related]
27. Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients.
Albu A; Radian S; Fica S; Barbu CG
Endocrine; 2015 Mar; 48(2):696-704. PubMed ID: 25022659
[TBL] [Abstract][Full Text] [Related]
28. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
29. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
[TBL] [Abstract][Full Text] [Related]
30. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women.
Kar S
J Hum Reprod Sci; 2013 Jul; 6(3):194-200. PubMed ID: 24347934
[TBL] [Abstract][Full Text] [Related]
31. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.
Krentowska A; Łebkowska A; Jacewicz-Święcka M; Hryniewicka J; Leśniewska M; Adamska A; Kowalska I
Endocrine; 2021 May; 72(2):400-410. PubMed ID: 33442790
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values.
Kim JJ; Hwang KR; Oh SH; Chae SJ; Yoon SH; Choi YM
Fertil Steril; 2019 Nov; 112(5):959-966.e1. PubMed ID: 31542165
[TBL] [Abstract][Full Text] [Related]
34. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.
Krentowska A; Kowalska I
Diabetes Metab Res Rev; 2022 Jan; 38(1):e3464. PubMed ID: 33988288
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
37. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
[TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome.
Mehrabian F; Jahanmardi R
Int J Prev Med; 2017; 8():79. PubMed ID: 29114377
[TBL] [Abstract][Full Text] [Related]
39. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
40. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
Ni RM; Mo Y; Chen X; Zhong J; Liu W; Yang D
Eur J Endocrinol; 2009 Sep; 161(3):411-8. PubMed ID: 19542239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
